106 related articles for article (PubMed ID: 30729508)
1. Construct validity and responsiveness of the Colombian version of Skindex-29.
Vasquez D; Aguirre DC; Sanclemente G
Br J Dermatol; 2019 Oct; 181(4):770-777. PubMed ID: 30729508
[TBL] [Abstract][Full Text] [Related]
2. The Brazilian version of Skindex-16 is a valid and reliable instrument to assess the health-related quality of life of patients with skin diseases.
Cárcano CBM; de Oliveira CZ; Paiva BSR; Paiva CE
PLoS One; 2018; 13(3):e0194492. PubMed ID: 29566036
[TBL] [Abstract][Full Text] [Related]
3. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16.
He Z; Lu C; Chren MM; Zhang Z; Li Y; Ni X; Buchtel V HA; Ryan PF; Li GZ
Health Qual Life Outcomes; 2014 Dec; 12():190. PubMed ID: 25539748
[TBL] [Abstract][Full Text] [Related]
4. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity.
AlGhamdi KM; AlShammari SA
Int J Dermatol; 2007 Mar; 46(3):247-52. PubMed ID: 17343578
[TBL] [Abstract][Full Text] [Related]
5. Translation and Validation of the Serbian Version of the Skindex-29 Instrument for Measuring Impact of Skin Disease on Quality of Life.
Milutinović JD; Krstić N; Janković SM
Acta Dermatovenerol Croat; 2017 Jul; 25(2):120-127. PubMed ID: 28871926
[TBL] [Abstract][Full Text] [Related]
6. The Spanish version of Skindex-29.
Jones-Caballero M; Peñas PF; García-Díez A; Badía X; Chren MM
Int J Dermatol; 2000 Dec; 39(12):907-12. PubMed ID: 11168659
[TBL] [Abstract][Full Text] [Related]
7. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases.
Higaki Y; Kawamoto K; Kamo T; Horikawa N; Kawashima M; Chren MM
J Dermatol; 2002 Nov; 29(11):693-8. PubMed ID: 12484430
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Skindex-29 Questionnaire: Portuguese Version (Portugal).
Carvalho D; Aguiar P; Palma-Carlos A
Acta Med Port; 2018 Sep; 31(9):463-469. PubMed ID: 30332369
[TBL] [Abstract][Full Text] [Related]
9. Turkish version of Skindex-29.
Aksu AE; Urer MS; Sabuncu I; Saracoglu ZN; Chren MM
Int J Dermatol; 2007 Apr; 46(4):350-5. PubMed ID: 17442071
[TBL] [Abstract][Full Text] [Related]
10. Skin-Related Quality of Life During Autoimmune Bullous Disease Course.
Hopkins ZH; Jimenez A; Taliercio VL; Clarke JT; Hansen CB; Hull CM; Rhoads JLW; Zone JJ; Sahni VN; Kean J; Secrest AM
JAMA Dermatol; 2023 Nov; 159(11):1185-1194. PubMed ID: 37703003
[TBL] [Abstract][Full Text] [Related]
11. Cross validation of the Turkish version of dermatology life quality index.
Oztürkcan S; Ermertcan AT; Eser E; Sahin MT
Int J Dermatol; 2006 Nov; 45(11):1300-7. PubMed ID: 17076710
[TBL] [Abstract][Full Text] [Related]
12. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases.
Chren MM; Lasek RJ; Sahay AP; Sands LP
J Cutan Med Surg; 2001; 5(2):105-10. PubMed ID: 11443481
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Skindex-16 questionnaire in patients with skin diseases in Morocco.
El Fakir S; Baybay H; Bendahhou K; Obtel M; Benchat L; Mernissi FZ; Nejjari C
J Dermatolog Treat; 2014 Apr; 25(2):106-9. PubMed ID: 22455447
[TBL] [Abstract][Full Text] [Related]
14. Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease.
Essa N; Awad S; Nashaat M
Int J Behav Med; 2018 Apr; 25(2):243-251. PubMed ID: 28748378
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease.
Smidt AC; Lai JS; Cella D; Patel S; Mancini AJ; Chamlin SL
Arch Dermatol; 2010 Aug; 146(8):865-9. PubMed ID: 20713817
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Skindex-16 construct validity in routinely collected psoriasis data: a retrospective analysis of the relationship between overall physician global assessment scores and Skindex-16 and measure discordance.
Hopkins ZH; Kuceki G; Taliercio VL; Snyder AM; Stoddard GJ; Duffin KC; Hess R; Secrest AM
Arch Dermatol Res; 2023 Jul; 315(5):1151-1159. PubMed ID: 36446939
[TBL] [Abstract][Full Text] [Related]
17. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases.
Chren MM; Lasek RJ; Flocke SA; Zyzanski SJ
Arch Dermatol; 1997 Nov; 133(11):1433-40. PubMed ID: 9371029
[TBL] [Abstract][Full Text] [Related]
18. Towards patient-centred cancer care: cross-cultural validity and responsiveness of the Turkish Integrated Palliative care Outcome Scale.
Hocaoglu MB; Hepgul N; Tunnard I; Meltem E; Efe H; Ataoglu B; Baybar YL; Kınacıgil M; Elsharairi H; Higginson IJ
Health Qual Life Outcomes; 2020 Sep; 18(1):312. PubMed ID: 32962717
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of the Arabic version of EORTC QLQ-C15-PAL among cancer patients in Jordan.
Alawneh A; Yasin H; Khirfan G; Qayas BA; Ammar K; Rimawi D; Klepstad P
Support Care Cancer; 2016 Jun; 24(6):2455-62. PubMed ID: 26660151
[TBL] [Abstract][Full Text] [Related]
20. Psychometric evaluation supported construct validity, temporal stability, and responsiveness of the Osteoarthritis Questionnaire.
Busija L; Osborne RH; Tatangelo G; Niutta S; Buchbinder R
J Clin Epidemiol; 2019 Oct; 114():11-21. PubMed ID: 31181260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
